Consolidated Statement Of Income

Kidswell Bio Corporation - Filing #7246134

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Consolidated statement of income
Statement of income
Net sales
5,082,053,000 JPY
4,930,345,000 JPY
2,431,236,000 JPY
Operating expenses
Selling, general and administrative expenses
1,612,236,000 JPY
1,027,355,000 JPY
2,374,980,000 JPY
Depreciation
896,000 JPY
896,000 JPY
917,000 JPY
Other
410,152,000 JPY
368,767,000 JPY
498,447,000 JPY
Operating expenses
Operating expenses
Operating expenses - general
Ordinary expenses
Interest expenses
Interest expenses on bonds
3,116,000 JPY
3,116,000 JPY
3,133,000 JPY
Cost of sales
3,441,934,000 JPY
3,441,934,000 JPY
1,391,852,000 JPY
Gross profit (loss)
1,640,119,000 JPY
1,488,411,000 JPY
1,039,383,000 JPY
Net sales
Operating profit (loss)
27,882,000 JPY
461,056,000 JPY
-1,335,597,000 JPY
Ordinary profit (loss)
5,187,000 JPY
583,882,000 JPY
-1,389,601,000 JPY
General and administrative expenses
Operating expenses
Research and development expenses
767,877,000 JPY
224,382,000 JPY
1,453,349,000 JPY
Extraordinary income
108,429,000 JPY
108,429,000 JPY
4,074,000 JPY
Selling, general and administrative expenses
Non-operating income
26,885,000 JPY
172,016,000 JPY
6,785,000 JPY
Interest income
767,000 JPY
1,761,000 JPY
8,000 JPY
Non-operating income
Miscellaneous income
221,000 JPY
204,000 JPY
2,437,000 JPY
Cost of sales
Non-operating expenses
Interest expenses
39,379,000 JPY
39,379,000 JPY
35,651,000 JPY
Non-operating expenses
49,580,000 JPY
49,189,000 JPY
60,789,000 JPY
Share issuance costs
1,495,000 JPY
1,495,000 JPY
2,063,000 JPY
Extraordinary losses
40,749,000 JPY
40,749,000 JPY
35,000,000 JPY
Impairment losses
6,444,000 JPY
6,444,000 JPY
JPY
Gross profit
Profit (loss) before income taxes
72,867,000 JPY
651,563,000 JPY
-1,420,527,000 JPY
Extraordinary income
Gain on sale of investment securities
66,330,000 JPY
66,330,000 JPY
JPY
Income taxes - current
94,008,000 JPY
93,828,000 JPY
1,551,000 JPY
Extraordinary losses
Income taxes
94,008,000 JPY
93,828,000 JPY
1,551,000 JPY
Profit (loss)
JPY
JPY
557,734,000 JPY
-21,140,000 JPY
557,734,000 JPY
JPY
557,734,000 JPY
JPY
JPY
JPY
557,734,000 JPY
JPY
JPY
JPY
-1,422,078,000 JPY
-1,422,078,000 JPY
-1,422,078,000 JPY
JPY
JPY
JPY
-1,422,078,000 JPY
Profit (loss) attributable to owners of parent
-21,140,000 JPY
JPY
-21,140,000 JPY
-21,140,000 JPY
JPY
JPY
JPY
JPY
JPY
Other comprehensive income
Valuation difference on available-for-sale securities
127,829,000 JPY
Other comprehensive income
127,829,000 JPY
Profit attributable to
Comprehensive income
106,688,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
106,688,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.